Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 247 of 6351
-
Can sound waves replace the scalpel for breast tumors?
Disease control Recruiting nowThis study will investigate Harmonic Motion Imaging guided Focused Ultrasound (HMIgFUS) method for ablation and sonoporation monitoring of breast tumors. The aim of this study is to evaluate the efficacy of real-time guidance/monitoring and ablation/sonoporation method. The hypot…
Phase 1 • Sponsor: Columbia University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Brain rescue: dual drug attack on Post-Arrest seizures shows promise
Disease control CompletedStatus epilepticus (SE) is found in 20-30% of patients in coma after cardiac arrest, is often refractory to medical therapy and is considered a negative prognostic factor. Intensity and duration of treatment of refractory and super-refractory post-anoxic SE pose the ethical dilem…
Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
One pill to prevent PTSD? hydrocortisone shows promise after trauma
Prevention CompletedThere is currently no evidence-based intervention for individuals exposed to trauma that is designed to aid recovery and prevent the development of post-traumatic stress disorder (PTSD). This randomized control trial proposes to test a one-time prophylactic treatment for the prev…
Phase 2 • Sponsor: Rachel Yehuda • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Can a higher dose of rifampicin clear TB around the heart faster?
Disease control CompletedThe investigators hypothesise that high dose RIF (RIF35) will increase pericardial fluid RIF exposure and so enhance mycobacterial clearance, compared to standard of care dosing (RIF10). This Phase 2b randomized, placebo-controlled, double-blinded trial will evaluate the efficac…
Phase 2 • Sponsor: University of Cape Town • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a weekly shot help children with achondroplasia grow taller?
Disease control CompletedPurpose of the study: The main purpose of this study is to determine the safety and evaluate the effect of a once weekly dose of TransCon CNP in prepubertal children with achondroplasia in China. Study Treatments: TransCon CNP is an investigational (new) drug, which means that…
Phase 2 • Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Brain surgery gets a GPS: network maps may help remove tumors while preserving function
Disease control Recruiting nowBrain tumor surgery in so-called "eloquent" brain areas aims to remove as much tumor as possible while preserving neurological functions. Standard surgical planning typically focuses on discrete, anatomically defined cortical regions. However, modern neuroscience demonstrates tha…
Sponsor: ARNAS Civico Di Cristina Benfratelli Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a diabetes drug tame fragile x symptoms?
Disease control CompletedThis study is a controlled trial of metformin in children with fragile X syndrome(FXS). The age of FXS children range from 2 to 16 years old. Participants will be randomized in a double-blind design to either drug or placebo for 6-month period. The primary objectives are to asses…
Phase 4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy aims to stop liver cancer from coming back
Disease control CompletedThis is an open-label,multi-center ,non-randomized ,single arm exploratory study . This clinical study is an investigator-initiated clinical trial(IIT ). The objective of this study is to evaluate if the addition of hepatic artery infusion chemotherapy (HAIC) and Donafenib after …
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Diabetes drug shows promise in preventing deadly transplant complication
Prevention CompletedPrimary Objective: It is hypothesized that the efficacy of Sitagliptin would reduce the incidence of grade II-IV acute Graft Versus Host Disease (GVHD) by day +100 post-transplant in patients undergoing alternative donor (related haploid or unrelated donor ) allogeneic Hematopoi…
Phase 3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
New pill could boost red blood cells in thalassemia patients
Disease control OngoingThe primary purpose of this study was to compare the effect of mitapivat versus placebo on hemolytic anemia in participants with alpha- or beta-non-transfusion dependent thalassemia (NTDT).
Phase 3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A machine that keeps donor livers alive outside the body — could it transform transplantation?
Disease control CompletedThis is a prospective, multi-center, controlled, randomized, pivotal study to evaluate the safety and effectiveness of the VitaSmart™ Liver Machine Perfusion System by comparing clinical outcomes in patients undergoing liver transplantation with ex-vivo liver preservation using s…
Sponsor: Bridge to Life Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Spit test could slash endometriosis diagnosis time
Diagnosis CompletedENDOmiARN Salive Test is a multicentre external validation study of a salivary signature of endometriosis carried out in France in Obstetrics and Reproductive Medicine departments, in order to evaluate its performance and discuss its use in clinical practice. The clinical applica…
Sponsor: ZIWIG • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New pill could slow MS relapses and disability
Disease control OngoingTo compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Ovarian cancer trial hopes immunotherapy can buy more time
Disease control OngoingThe primary objective is to compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by the i…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can immunotherapy let doctors dial down cancer treatment without sacrificing cures?
Disease control Recruiting nowTo determine if it is feasible to use neoadjuvant immunotherapy (or immunotherapy plus chemotherapy) to reduce treatment intensity and improve long-term quality of life while maintaining very high cure rates.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a new drug combo revive the immune System's attack on resistant cancers?
Disease control CompletedThe primary goal of this trial is to assess clinical response to nivolumab and pixatimod, and, nivolumab, pixatimod and cyclophosphamide in three separate patient cohorts. Cohort 1: MSS mCRC in combination with low-dose cyclophosphamide, Cohort 2: PD-1 relapsed/refractory melanom…
Phase 2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New inhaler aims to halt seizures in seconds
Disease control Recruiting nowThe purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IM…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could estrogen patch reverse liver damage in postmenopausal women?
Disease control OngoingNon-alcoholic fatty liver disease (NAFLD) is a growing epidemic in the United States. Despite this, the treatment options remain limited. Preclinical and preliminary clinical data suggest that estrogen deficiency plays an important role in the pathology of steatosis, inflammation…
Phase 3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
Diagnosis CompletedStool4TB aims to evaluate an innovative stool-based qPCR diagnostic platform (with the capacity to become a POC diagnostic tool) in the high TB and HIV burden settings of Mozambique, Eswatini and Uganda, under the hypothesis that it will narrow the extremely large TB case detecti…
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Can a cell therapy shrink Hard-to-Treat lung tumors?
Disease control Stopped earlyPhase I Part : Confirm the safety of GAIA-102 alone or GAIA-102 with pembrolizumab for advanced / relapse non-small cell lung cancer, and decide recommended dose for Phase II. Phase II Part : Explore the efficacy and safety of GAIA-102 alone or GAIA-102 with pembrolizumab for …
Phase 1/2 • Sponsor: GAIA BioMedicine Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC